Personalized Medicine in Coronary Artery Disease: Where Are We in 2022?

J Pers Med. 2022 Sep 1;12(9):1446. doi: 10.3390/jpm12091446.

Authors

Dmitry Shchekochikhin¹, Philipp Kopylov²

Affiliations

¹ Department of Cardiology, Functional and Ultrasound Diagnostics, Sechenov First Moscow State Medical University (Sechenov University), Moscow 119435, Russia.
² Institute of Personalized Cardiology, Sechenov First Moscow State Medical University (Sechenov University), Moscow 119435, Russia.

Abstract

Coronary artery disease (CAD) is the leading cause of morbidity and mortality in developed and in most developing countries [...].

Publication types

Editorial

Grants and funding

This research received no external funding.